DOP2013000030A - Compuesto heterociclico y su uso - Google Patents

Compuesto heterociclico y su uso

Info

Publication number
DOP2013000030A
DOP2013000030A DO2013000030A DO2013000030A DOP2013000030A DO P2013000030 A DOP2013000030 A DO P2013000030A DO 2013000030 A DO2013000030 A DO 2013000030A DO 2013000030 A DO2013000030 A DO 2013000030A DO P2013000030 A DOP2013000030 A DO P2013000030A
Authority
DO
Dominican Republic
Prior art keywords
compound
heterociclical
saies
isoxazolepropionic
adhd
Prior art date
Application number
DO2013000030A
Other languages
English (en)
Inventor
Osamu Ujikawa
Masakuni Kori
Eiji Honda
Toshihiro Imaeda
Shinji Nakamura
Masashi Toyofuku
Yasutomi Asano
Michiyo Mochizuki
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of DOP2013000030A publication Critical patent/DOP2013000030A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporciona un compuesto representado por la fórmula (l): en donde cada símbolo es como se define en la memoria descriptiva o una de sus saies, que tiene una acción potenciadora del receptor de AM PA (ácido a—amino—3—h idroxi—5—metil—4—isoxazolpropiónico). El compuesto de la presente invención es de utilidad como un fármaco preventivo o terapéutico para depresión, esquizofrénia, enfermedad de Alzheimer o trastorno de hiperactividad de déficit de atención (ADHD), y sim ilares.
DO2013000030A 2010-08-10 2013-02-05 Compuesto heterociclico y su uso DOP2013000030A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2010179577 2010-08-10

Publications (1)

Publication Number Publication Date
DOP2013000030A true DOP2013000030A (es) 2013-03-15

Family

ID=44534564

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2013000030A DOP2013000030A (es) 2010-08-10 2013-02-05 Compuesto heterociclico y su uso

Country Status (38)

Country Link
US (10) US9150591B2 (es)
EP (1) EP2603513B1 (es)
JP (2) JP5788496B2 (es)
KR (1) KR101852215B1 (es)
CN (2) CN103180326B (es)
AR (1) AR082618A1 (es)
AU (1) AU2011290126B2 (es)
BR (1) BR112013002250B1 (es)
CA (1) CA2807460C (es)
CL (1) CL2013000380A1 (es)
CO (1) CO6680700A2 (es)
CR (1) CR20130066A (es)
CY (1) CY1123507T1 (es)
DK (1) DK2603513T3 (es)
DO (1) DOP2013000030A (es)
EA (1) EA022078B1 (es)
EC (1) ECSP13012478A (es)
ES (1) ES2793723T3 (es)
GE (1) GEP20156216B (es)
HR (1) HRP20200844T1 (es)
HU (1) HUE049460T2 (es)
IL (1) IL224452A (es)
LT (1) LT2603513T (es)
MA (1) MA34509B1 (es)
MX (1) MX349470B (es)
MY (1) MY165908A (es)
NZ (1) NZ607593A (es)
PE (1) PE20131116A1 (es)
PL (1) PL2603513T3 (es)
PT (1) PT2603513T (es)
RS (1) RS60311B1 (es)
SG (1) SG187656A1 (es)
SI (1) SI2603513T1 (es)
TW (1) TWI504604B (es)
UA (1) UA111594C2 (es)
UY (1) UY33551A (es)
WO (1) WO2012020848A1 (es)
ZA (1) ZA201301120B (es)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR082618A1 (es) * 2010-08-10 2012-12-19 Takeda Pharmaceutical Derivados de tiadiazina, composiciones farmaceuticas y usos
WO2012137982A2 (en) * 2011-04-05 2012-10-11 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
WO2013118845A1 (ja) * 2012-02-08 2013-08-15 武田薬品工業株式会社 複素環化合物およびその用途
CA2915405A1 (en) * 2013-06-13 2014-12-18 Veroscience Llc Compositions and methods for treating metabolic disorders
CN105324376B (zh) 2013-06-27 2017-06-23 辉瑞大药厂 杂芳族化合物及其作为多巴胺d1配体的用途
US11589583B2 (en) 2013-12-03 2023-02-28 Fmc Corporation Pyrrolidinones herbicides
SI3077374T1 (sl) 2013-12-03 2020-07-31 Fmc Corporation Pirolidinoni kot herbicidi
AU2015284280C1 (en) 2014-07-02 2020-02-13 Fmc Corporation Piperidinone herbicides
BR112017009701B1 (pt) 2014-12-08 2021-09-08 Fmc Corporation Composto e métodos de preparação de compostos
BR112017017945B1 (pt) 2015-04-10 2021-06-08 Fmc Corporation composto, composições herbicidas, mistura herbicida e método de controle do crescimento de vegetação indesejada
WO2016176082A1 (en) 2015-04-27 2016-11-03 E I Du Pont De Nemours And Company Butyrolactones as herbicides
BR112017023038A2 (pt) * 2015-04-29 2018-07-03 Janssen Pharmaceutica Nv imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa
WO2016176460A1 (en) 2015-04-29 2016-11-03 Janssen Pharmaceutica Nv Azabenzimidazoles and their use as ampa receptor modulators
CN107592862B (zh) 2015-05-12 2021-06-15 Fmc公司 作为除草剂的芳基取代的双环化合物
US10906873B2 (en) 2015-05-29 2021-02-02 Fmc Corporation Substituted cyclic amides as herbicides
EP3303321A1 (en) 2015-06-02 2018-04-11 E. I. du Pont de Nemours and Company Substituted cyclic amides and their use as herbicides
AU2016303209B2 (en) 2015-07-31 2021-04-01 Fmc Corporation Cyclic N-carboxamide compounds useful as herbicides
SI3331892T1 (sl) * 2015-08-06 2019-10-30 Hoffmann La Roche Postopki za pripravo derivatov gaINAc kisline
TW201713774A (zh) 2015-08-06 2017-04-16 Kohjin Life Sciences Co Ltd 含有β-菸鹼醯胺單核苷酸的酵母萃取物及其製造方法
US20170181292A1 (en) * 2015-12-16 2017-06-22 Rohm And Haas Electronic Materials Llc Method for forming organic coating on nickel surface
CN105669731B (zh) * 2016-01-10 2017-06-30 沧州普瑞东方科技有限公司 一种4‑(4‑烷基环己氧基)苯硼酸的合成方法
BR112019012910B1 (pt) 2016-12-21 2023-10-17 Fmc Corporation Composto, composição herbicida, mistura herbicida e método para controlar o crescimento de vegetação indesejável
CN107892697B (zh) 2016-12-26 2020-11-03 郑州泰基鸿诺医药股份有限公司 一种[1,3]噻嗪-2-胺类化合物及应用，药物组合物
BR112019019605B1 (pt) 2017-03-21 2023-03-07 Fmc Corporation Compostos e processo para preparar um composto de fórmula ii-a
CA3057300A1 (en) 2017-03-21 2018-09-27 Fmc Corporation Herbicidal mixture, composition and method
AR111967A1 (es) 2017-05-30 2019-09-04 Fmc Corp Amidas herbicidas
AR111839A1 (es) 2017-05-30 2019-08-21 Fmc Corp Lactamas 3-sustituidas herbicidas
EP3693368B1 (en) * 2017-10-06 2023-12-06 Takeda Pharmaceutical Company Limited Heterocyclic compound
EP3693360B1 (en) * 2017-10-06 2023-12-13 Takeda Pharmaceutical Company Limited Heterocyclic compounds
EP4149478A1 (en) 2020-05-15 2023-03-22 Takeda Pharmaceutical Company Limited Treatment for depression

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0437742Y2 (es) 1986-10-22 1992-09-04
JPH0285851A (ja) * 1988-09-22 1990-03-27 Konica Corp 新規な写真用カプラー
JPH037742A (ja) 1989-06-05 1991-01-14 Toyo Tire & Rubber Co Ltd ラバーチエーン用ゴム組成物
JP2874960B2 (ja) * 1990-06-03 1999-03-24 コニカ株式会社 新規な染料を含有するハロゲン化銀写真感光材料
JPH04119890A (ja) 1990-09-11 1992-04-21 Konica Corp ピラゾロチアジアジン系色素
JP3430375B2 (ja) 1993-11-12 2003-07-28 コニカ株式会社 感熱転写材料及び該材料に好適な色素
DE19704923A1 (de) 1997-02-10 1998-08-13 Hoechst Schering Agrevo Gmbh Klebstoffhaltige Schädlingsbekämpfungsmittel
JP2003526341A (ja) 1999-11-04 2003-09-09 コロラド ステート ユニバーシティー リサーチ ファウンデーション 昆虫を誘引するための装置および方法
FR2801587B1 (fr) 1999-11-30 2002-01-11 Adir Nouveaux derives de benzothiadiazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2005508352A (ja) * 2001-10-10 2005-03-31 ニューロサーチ、アクティーゼルスカブ 新規ベンゾチアジン誘導体、その製造方法及びその使用方法
FR2833955B1 (fr) * 2001-12-21 2004-01-30 Servier Lab Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2854634B1 (fr) 2003-05-05 2005-07-08 Servier Lab Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2865474B1 (fr) 2004-01-26 2008-06-13 Servier Lab Nouveaux derives de benzothiazines fluorees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2879201B1 (fr) * 2004-12-10 2007-02-16 Servier Lab Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
AU2007100527A4 (en) 2006-06-23 2007-08-23 Nufarm Australia Limited Phenoxy alkanoate herbicidal composition and method of preparation and use
EP2102153A1 (en) * 2006-12-11 2009-09-23 Eli Lilly & Company Ampa receptor potentiators
US20080167374A1 (en) 2007-01-09 2008-07-10 Loveland Products, Inc. Pesticide composition and method of use
JP2011503002A (ja) * 2007-11-05 2011-01-27 シェーリング コーポレイション γセクレターゼ調節剤
WO2009086303A2 (en) * 2007-12-21 2009-07-09 University Of Rochester Method for altering the lifespan of eukaryotic organisms
EP2269990A4 (en) 2008-03-25 2012-04-18 Takeda Pharmaceutical HETEROCYCLIC COMPOUND
JP2009248543A (ja) * 2008-04-11 2009-10-29 Fujifilm Corp 光情報記録媒体および情報記録方法
TW201012803A (en) 2008-06-06 2010-04-01 Organon Nv Heterocyclic derivatives
AU2009313527A1 (en) 2008-11-06 2010-05-14 Merck Sharp & Dohme Corp. Gamma secretase modulators
TW201030002A (en) 2009-01-16 2010-08-16 Bristol Myers Squibb Co Bicyclic compounds for the reduction of beta-amyloid production
JP2012051806A (ja) 2009-02-26 2012-03-15 Eisai R & D Management Co Ltd イミダゾリルピラジン誘導体
FR2943342B1 (fr) 2009-03-20 2011-03-04 Servier Lab Nouveaux derives de benzothiadiazepines,leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
WO2010140339A1 (ja) 2009-06-01 2010-12-09 武田薬品工業株式会社 複素環化合物
JPWO2011007756A1 (ja) 2009-07-13 2012-12-27 武田薬品工業株式会社 複素環化合物及びその用途
WO2011036889A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
WO2011036885A1 (ja) 2009-09-25 2011-03-31 武田薬品工業株式会社 複素環化合物
AR082618A1 (es) * 2010-08-10 2012-12-19 Takeda Pharmaceutical Derivados de tiadiazina, composiciones farmaceuticas y usos

Also Published As

Publication number Publication date
ES2793723T3 (es) 2020-11-16
UY33551A (es) 2012-03-30
HUE049460T2 (hu) 2020-09-28
SG187656A1 (en) 2013-03-28
US11279713B2 (en) 2022-03-22
US20180162875A1 (en) 2018-06-14
US20130190291A1 (en) 2013-07-25
US9884875B2 (en) 2018-02-06
JP2016006080A (ja) 2016-01-14
TWI504604B (zh) 2015-10-21
US20150353578A1 (en) 2015-12-10
TW201217386A (en) 2012-05-01
EP2603513A1 (en) 2013-06-19
US8916551B2 (en) 2014-12-23
CL2013000380A1 (es) 2013-05-31
GEP20156216B (en) 2015-01-12
US20140080817A1 (en) 2014-03-20
AU2011290126B2 (en) 2016-01-07
EA022078B1 (ru) 2015-10-30
SI2603513T1 (sl) 2020-07-31
UA111594C2 (uk) 2016-05-25
RS60311B1 (sr) 2020-07-31
WO2012020848A1 (en) 2012-02-16
CY1123507T1 (el) 2022-03-24
US9150591B2 (en) 2015-10-06
KR101852215B1 (ko) 2018-04-25
US9499568B2 (en) 2016-11-22
IL224452A (en) 2017-11-30
CN103180326A (zh) 2013-06-26
NZ607593A (en) 2015-01-30
AU2011290126A1 (en) 2013-03-07
CN103180326B (zh) 2015-06-10
DK2603513T3 (da) 2020-06-15
ECSP13012478A (es) 2013-04-30
MA34509B1 (fr) 2013-09-02
BR112013002250A2 (pt) 2016-05-24
US8575154B2 (en) 2013-11-05
AR082618A1 (es) 2012-12-19
MX349470B (es) 2017-07-31
WO2012020848A8 (en) 2012-09-27
CN104926837A (zh) 2015-09-23
BR112013002250B1 (pt) 2020-10-27
MY165908A (en) 2018-05-18
MX2013001614A (es) 2013-07-05
PE20131116A1 (es) 2013-10-24
HRP20200844T1 (hr) 2020-08-21
PL2603513T3 (pl) 2020-07-27
US20150073137A1 (en) 2015-03-12
LT2603513T (lt) 2020-05-25
JP6113789B2 (ja) 2017-04-12
EA201390222A1 (ru) 2013-08-30
US20190263832A1 (en) 2019-08-29
CA2807460C (en) 2018-09-18
US20200317692A1 (en) 2020-10-08
US20170022222A1 (en) 2017-01-26
US20120077799A1 (en) 2012-03-29
PT2603513T (pt) 2020-06-08
CA2807460A1 (en) 2012-02-16
ZA201301120B (en) 2014-04-30
US10654874B2 (en) 2020-05-19
US8778934B2 (en) 2014-07-15
KR20130138738A (ko) 2013-12-19
CR20130066A (es) 2013-05-03
JP2013535408A (ja) 2013-09-12
CO6680700A2 (es) 2013-05-31
JP5788496B2 (ja) 2015-09-30
EP2603513B1 (en) 2020-03-11
US20130184266A1 (en) 2013-07-18

Similar Documents

Publication Publication Date Title
DOP2013000030A (es) Compuesto heterociclico y su uso
ECSP14013329A (es) Compuestos de arylcarbonil-4-oxy-piperidina utilizados para el tratamiento de enfermedades neurodegenerativas
GT201200220A (es) Ciertas triazolopiridinas y triazolopirazinas, composiciones de estas y sus métodos de empleo
CR20110103A (es) Heteroarilos sustituidos
CO6311079A2 (es) Derivados de aminodihidrotiazina como inhibidores de la enzima bace para el tratamiento de la enfermedad de alzheimer
ECSP13012611A (es) Derivados de pirazol-aminopirimidina como moduladores de la lrrk2
CL2014000210A1 (es) Una composicion de prodroga que comprende al menos un conjugado de metilfenidato; kit farmaceutico que la comprende, util para el tratamiento de una enfermedad o condicion que requiere estimulacion del sistema nervioso tal como un trastorno de hiperactividad con deficit de atencion y depresion.
CO6430427A2 (es) Derivados de benzofuranilo
NI201000035A (es) Derivados de azaciclilisoquinolinona e isoindolinona como antagonistas de histamina-3
CO7071139A2 (es) Tratamiento contra el cáncer cerebral
CO7350640A2 (es) Compuestos diméricos
DOP2010000321A (es) Derivados de iminopirimidina y su uso
CO6300955A2 (es) Derivados de isoquinolinilo e isoindolinilo como antagonistas de la histamina -3
CO6491037A2 (es) Derivados de pirazinooxazepina
CL2017000069A1 (es) Derivado de hidantoina.
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CO6341625A2 (es) Derivados de indol como agentes anticáncer
CL2016000884A1 (es) Derivados de piperazina y su uso como medicamento.
CR20150148A (es) Azaindolinas
CR9733A (es) Derivados de azinil-3-sulfonilindazol como ligandos de 5-hidroxitriptamina-6
BR112017011777A2 (pt) antagonista de a2a de dosagem baixa para o tratamento de tdah e doença de parkinson
BR112013000941A2 (pt) formulações de 14-epi-análogos de vitamina d
ECSP088930A (es) Derivados de benzoxazol y benzotiazol como ligandos de
CU20110020A7 (es) Compuestos de fenantrenona, composiciones y métodos
UY32448A (es) Derivados de 3-benzofuranil-indol-2-ona-3-acetamidopiperazinas sustituidos, su preparacion y su aplicacion en terapeutica